🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
A phase 3, randomized, double-blind trial to evaluate the safety and immuno...
Status
Completed
Location
Seishinkai Inoue Hospital
Start Date
2021-06-14
Trial ID
NCT04875533
The purpose of this study is to evaluate the safety and immune response of ...
Status
Completed
Location
University of Rochester
Start Date
2000-11
Trial ID
NCT00133549
Treatments Being Tested
A growing number of patients with Crohn's disease are treated with immunosu...
Status
Completed
Location
Yonsei University: Wonju Christian Hospital
Start Date
2011-12
Trial ID
NCT01505855
Treatments Being Tested
The current study provides data necessary to evaluate the safety and immuno...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-25
Trial ID
NCT05140720
Treatments Being Tested
Immune response analysis after the combination of PCV13 and PPV23 will lead...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT02279589
Treatments Being Tested
Previous studies have demonstrated the immunogenicity and safety of the co-...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2012-10
Trial ID
NCT02582047
Treatments Being Tested
This randomized clinical trial (RCT) evaluates whether metformin can reduce...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-04-07
Trial ID
NCT06829238
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested